AMM01503G

antibody from Leading Biology
Targeting: CD19
Provider product page for AMM01503G
Immunocytochemistry
Flow cytometry

Antibody data

Product number
AMM01503G - Provider product page
Provider
Leading Biology
Product name
CD19 (B-Lymphocyte Marker) Antibody - With BSA and Azide
Antibody type
Monoclonal
Description
CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
Reactivity
Human
Host
Mouse
Antibody clone number
C19/366
Storage
Store at +4°C short term. For long-term storage, aliquot and store at -20°C or below. Stable for 12 months at -20°C. Avoid repeated freeze-thaw cycles.
CD19 protein structure - AMM01503G shown in red.